First U.S. patient receives autologous stem cell therapy to treat dry AMD
| Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
08/31/2022 02:45 PM EDT Dry AMD is a leading cause of vision loss among older Americans. |


Comments
Post a Comment